TAFINLAR HARD CAPSULE 75MG
Product details
Registration number: SIN14831P
Classification: Prescription Only
Active ingredients: Dabrafenib Mesylate 88.88mg equivalent to dabrafenib
Strength: 75mg
Dosage form: CAPSULE
Route: ORAL
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: L01EC02
HSA approval date: 24 August 2015
Manufacturer(s):
- Siegfried Barbera S.L.
- Novartis Pharmaceutical Manufacturing LLC
Manufacturing country/countries: SLOVENIA; SPAIN
What are the HSA registration number and classification for TAFINLAR HARD CAPSULE 75MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14831P
Classification: Prescription Only
What active ingredients and strength are recorded for TAFINLAR HARD CAPSULE 75MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Dabrafenib Mesylate 88.88mg equivalent to dabrafenib
Strength: 75mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TAFINLAR HARD CAPSULE 75MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for TAFINLAR HARD CAPSULE 75MG?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for TAFINLAR HARD CAPSULE 75MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Siegfried Barbera S.L.
- Novartis Pharmaceutical Manufacturing LLC
Manufacturing country/countries: SLOVENIA; SPAIN
Where can I look up TAFINLAR HARD CAPSULE 75MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14831P or the exact product name TAFINLAR HARD CAPSULE 75MG. The general register link does not preselect this product.
What are the source dates for this TAFINLAR HARD CAPSULE 75MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TAFINLAR HARD CAPSULE 75MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14831P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)